Statin Drug Production Resumes at Ranbaxy

Ranbaxy, which had more than 40 percent of the United States market for generic Lipitor in October, said it had been working with the F.D.A. to solve quality problems in making the drug.
Source: NYT Health - Category: Consumer Health News Authors: Tags: India Pfizer Inc PFE NYSE Drugs (Pharmaceuticals) Food and Drug Administration Ranbaxy Laboratories Lipitor (Drug) Food Contamination and Poisoning Source Type: news